Netherlands · Series A startup

Who invested in Enzyre

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

Healthcare

Funding summaryUpdated 26 Oct 2026

$12Mraised across 1 round since 2022, from 1 source

Latest round
Series A, $12MNov 2022
Investors
1
See who backed them

The rounds

  1. Nov 2022
    Series A$12M

    Source recorded

Everyone who backed them

OostNLVC firm1round

Missing a round, or an investor who was in one? Tell us.

Also claim to have backed them

This firm lists Enzyre as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.

Novalis BiotechVC firmPer its own site

Quick answers about Enzyre

Who invested in Enzyre?

Enzyre's investors include OostNL.

How much has Enzyre raised?

Enzyre has raised $12M across 1 round since 2022.

When did Enzyre last raise?

Enzyre's most recent round was a Series A of $12M in Nov 2022.

What was Enzyre's biggest round?

Its most recent round, $12M in Nov 2022, is also its largest on record.

Who backed Enzyre first?

Enzyre's first round on record, in Nov 2022, was backed by OostNL.

What stage is Enzyre at?

Enzyre's latest named round is a Series A, in Nov 2022.

Where is Enzyre based?

Enzyre is based in the Netherlands.

Companies like Enzyre

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.